WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017059062) THALIDOMIDE ANALOGS AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/059062    International Application No.:    PCT/US2016/054430
Publication Date: 06.04.2017 International Filing Date: 29.09.2016
IPC:
C07D 401/14 (2006.01), C07D 401/04 (2006.01), C07D 417/04 (2006.01), C07D 499/80 (2006.01), C07D 209/44 (2006.01), C07D 209/46 (2006.01), C07D 209/48 (2006.01), C07D 209/52 (2006.01), A61K 31/4035 (2006.01), A61K 31/43 (2006.01), A61P 35/00 (2006.01), A61P 37/02 (2006.01), A61P 29/00 (2006.01)
Applicants: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, MD 20852-7660 (US).
UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN [GB/GB]; University Office Kings College Aberdeen AB24 3FX (GB)
Inventors: GREIG, Nigel, H.; (US).
LUO, Weiming; (US).
TWEEDIE, David; (US).
VARGESSON, Neil; (GB).
BEEDIE, Shaunna; (GB).
FIGG, William, Douglas; (US)
Agent: GARDNER, Gillian; (US)
Priority Data:
62/235,105 30.09.2015 US
Title (EN) THALIDOMIDE ANALOGS AND METHODS OF USE
(FR) ANALOGUES DE LA THALIDOMIDE ET LEURS PROCÉDÉS D'UTILISATION
Abstract: front page image
(EN)Thalidomide analogs and methods of using the thalidomide analogs are disclosed. Some embodiments of the disclosed compounds exhibit anti- angiogenic and/or anti-inflammatory activity. Certain embodiments of the disclosed compounds are non-teratogenic.
(FR)L’invention concerne des analogues de la thalidomide et des procédés d'utilisation de ces analogues. Dans certains modes de réalisation, les composés de la présente invention présentent une activité anti-angiogénique et/ou anti-inflammatoire. Dans d’autres modes de réalisation, les composés de l'invention sont non-tératogènes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)